NDC 50090-5491-01 - Cyproheptadine Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-5491
- Requested NDC
- 50090-5491-01
- Package NDCs from labels
- 50090-5491-0, 50090-5491-1, 50090-5491-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2023-09-18
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Cyproheptadine Hydrochloride - A-S Medication Solutions | A-S Medication Solutions | 2023-09-18 | Human Prescription Drug Label |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 50090-5491-0 | 2023-02-07 | CYPROHEPTADINE HYDROCHLORIDE TABLETS USP |
| 50090-5491-1 | 2023-02-07 | CYPROHEPTADINE HYDROCHLORIDE TABLETS USP |
| 50090-5491-0 | 2023-01-30 | CYPROHEPTADINE HYDROCHLORIDE TABLETS USP |
| 50090-5491-1 | 2023-01-30 | CYPROHEPTADINE HYDROCHLORIDE TABLETS USP |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-5491-0 | Cyproheptadine Hydrochloride | 100 in 1 BOTTLE | TABLET | 100 | 4 | |
| 50090-5491-1 | Cyproheptadine Hydrochloride | 30 in 1 BOTTLE | TABLET | 30 | 4 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-5491 | CYPROHEPTADINE HYDROCHLORIDE TABLET [A-S MEDICATION SOLUTIONS] | 4 | Current NDC, Legacy NDC, 2 package rows | 20230919_7e156e5e-e4cc-420b-8f1a-af123eaa9156.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-5491-1 | EA - Each | 50090-5491 | dcdc515e-deb0-48bf-b4b8-189216fce102 | 1 | 2023-10-16 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CYPROHEPTADINE HYDROCHLORIDE | CYPROHEPTADINE HYDROCHLORIDE | Zydus Lifesciences Limited | ccd7d3b2-b0c1-4f66-8d06-d21f5cfa8c1e | 2024-11-26 | 866144 NJ82J0F8QC | |
| CYPROHEPTADINE HYDROCHLORIDE | CYPROHEPTADINE HYDROCHLORIDE | Bryant Ranch Prepack | 5d0db096-f35d-4065-bff1-2fd7ef5a1a6f | 2024-08-20 | Warnings, Adverse reactions | 866144 NJ82J0F8QC |
| CYPROHEPTADINE HYDROCHLORIDE | CYPROHEPTADINE HYDROCHLORIDE | QUAGEN PHARMACEUTICALS LLC | d3ce21de-849a-47ab-8405-968d8de6f1e9 | 2024-06-15 | Warnings, Adverse reactions | NJ82J0F8QC |
| Cyproheptadine Hydrochloride | CYPROHEPTADINE HYDROCHLORIDE | Bryant Ranch Prepack | 6a5b5a89-82c2-4991-b026-d160d8fa59a3 | 2024-05-23 | Warnings, Adverse reactions | 866144 NJ82J0F8QC |
| CYPROHEPTADINE HYDROCHLORIDE | CYPROHEPTADINE HYDROCHLORIDE | Bryant Ranch Prepack | ab58d4df-69d4-43ac-ac6c-871fcc6c946d | 2023-11-28 | Warnings, Adverse reactions | 866144 NJ82J0F8QC |
| CYPROHEPTADINE HYDROCHLORIDE | CYPROHEPTADINE HYDROCHLORIDE | A-S Medication Solutions | 0e43e99b-2e0b-4f55-b93a-a6908634880d | 2023-11-02 | Warnings, Adverse reactions | 866144 NJ82J0F8QC |
| CYPROHEPTADINE | CYPROHEPTADINE HYDROCHLORIDE | Chartwell RX, LLC | 37fe7264-4d45-4d6c-ac13-40fcd1d82351 | 2023-10-05 | Warnings, Adverse reactions | NJ82J0F8QC |
| Cyproheptadine Hydrochloride | CYPROHEPTADINE HYDROCHLORIDE | A-S Medication Solutions | 7e156e5e-e4cc-420b-8f1a-af123eaa9156 | 2023-09-18 | Warnings, Adverse reactions | ANDA206553 50090-5491-0 50090-5491-1 50090-5491 50090549101 866144 28b91c2a-e33a-4b09-8636-4c53ea6f1358 7e156e5e-e4cc-420b-8f1a-af123eaa9156 NJ82J0F8QC |
| CYPROHEPTADINE HYDROCHLORIDE | CYPROHEPTADINE HYDROCHLORIDE | Bryant Ranch Prepack | 1bfb14ad-b522-4ad6-8c9f-2d99dd0dce64 | 2023-08-15 | Warnings, Adverse reactions | 866144 NJ82J0F8QC |
| Cyproheptadine Hydrochloride | CYPROHEPTADINE HYDROCHLORIDE | Chartwell RX, LLC | 029ed3b6-175e-4a1a-81ed-350bff5f6167 | 2023-01-27 | Warnings, Adverse reactions | 866144 NJ82J0F8QC |
| CYPROHEPTADINE HYDROCHLORIDE | CYPROHEPTADINE HYDROCHLORIDE | Zydus Pharmaceuticals USA Inc. | 766f9b59-2c72-45ac-af09-5dd6c3e16b52 | 2022-10-04 | Warnings, Adverse reactions | 866144 NJ82J0F8QC |
| CYPROHEPTADINE HYDROCHLORIDE | CYPROHEPTADINE HYDROCHLORIDE | QUAGEN PHARMACEUTICALS LLC | 98e71865-83dd-4e29-8308-c56e36731d96 | 2022-07-08 | Warnings, Adverse reactions | 866144 NJ82J0F8QC |
| Cyproheptadine Hydrochloride | CYPROHEPTADINE HYDROCHLORIDE | Tris Pharma Inc | 2b438746-14c2-44ef-a127-62b8d2efdc55 | 2022-03-15 | Warnings, Adverse reactions | NJ82J0F8QC |
| Cyproheptadine Hydrochloride | CYPROHEPTADINE HYDROCHLORIDE | Rising Pharma Holdings, Inc. | c5e9e983-d0d2-4f87-beae-0d853ca43983 | 2022-02-08 | Warnings, Adverse reactions | 866144 NJ82J0F8QC |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.